ATP-dependent chromatin-remodeling factors use the energy of ATP hydrolysis to alter the structure of chromatin and are important regulators of eukaryotic gene expression. One such factor encoded by CHR5 (ChromatinRemodeling Factor 5) in Arabidopsis (Arabidopsis thaliana) was previously found to be involved in regulation of growth and development. Here we show that CHR5 is required for the up-regulation of the intracellular immune receptor gene SNC1 (SUPPRESSOR OF npr1-1, CONSTITUTIVE1) and consequently the autoimmunity induced by SNC1 up-regulation. CHR5 functions antagonistically with another chromatin-remodeling gene DDM1 (DECREASED DNA METHYLATION 1) and independently with a histone mono-ubiquitinase HUB1 (HISTONE MONOUBIQUITINATION 1) in SNC1 regulation. In addition, CHR5 is a positive regulator of SNC1-independent plant immunity against the bacterial pathogen Pseudomonas syringae. Furthermore, the chr5 mutant has increased nucleosome occupancy in the promoter region relative to the gene body region at the whole-genome level, suggesting a global role for CHR5 in remodeling nucleosome occupancy. Our study thus establishes CHR5 as a positive regulator of plant immune responses including the expression of SNC1 and reveals a role for CHR5 in nucleosome occupancy which probably impacts gene expression genome wide.
Introduction
Plant immunity consists of several layers of defense responses, each induced by a specific recognition of pathogen features by plant receptors Jones 2001, Jones and Dangl 2006) . One layer, called effector-triggered immunity (ETI), is largely mediated by resistance (R) proteins that directly or indirectly detect the presence of pathogen effectors. The majority of the R genes encode Nod-like receptor (NLR) proteins which consist of nucleotide-binding and leucine-rich repeat domains. Fine tuning of NLR expression is critical for effective defense responses and a balance between defense activation and plant growth Jones 2001, Hua 2013) . Although NLRmediated immunity has been studied in considerable detail in plants, the molecular mechanisms underlying regulation of its expression is still not fully understood.
The SNC1 (SUPPRESSOR OF npr1-1, CONSTITUTIVE1) is an NLR gene residing in a gene cluster containing seven NLR genes including RPP4 which is responsible for the recognition of and resistance to specific pathovars of downy mildew in Arabidopsis (Noel et al. 1999) . It functions as a minor NLR gene for resistance to the effector AvrRps4 when the major NLR gene RPS4 (RESISTANCE TO PSEUDOMONAS SYRINGAE4) is absent (Kim et al. 2010) . SNC1 is under multiple levels of regulation including transcriptional and post-transcriptional (Gou and Hua 2012) . It was shown to be co-ordinately regulated with other NLR genes in the cluster by RNAdependent gene silencing (Yi and Richards 2007) . Transgene analysis indicates that additional cis-elements are required for its expression regulation beyond the usual length of the flanking upstream and downstream sequences ). The SNC1 gene is induced by pathogen infection, which probably contributes to plant immunity (Zou et al. 2014) . Its gain-offunction mutant snc1-1 (referred to as snc1) has constitutive defense responses or autoimmune responses associated with high accumulation of salicylic acid (SA) and high expression of PR (pathogenesis-related) genes in the absence of pathogens (Zhang et al. 2003) . SNC1 itself is up-regulated in snc1, probably due to a feedback regulation from activated SNC1 protein (Yang and Hua 2004) . It is negatively regulated by an evolutionarily conserved calcium-binding protein BON1 (BONZAI1), and the BON1 loss-of-function (LOF) mutant has a high SNC1 expression leading to an autoimmune phenotype similar to that in snc1 (Hua et al. 2001 , Yang and Hua 2004 , Yang et al. 2006 . Up-regulation of SNC1 in bon1 and snc1 provides a good system to study the regulation of NLR genes and immune responses. Several regulators of SNC1 at the chromatin level have been isolated as suppressors of bon1 or snc1. MOS1 (MODIFIER OF snc1, 1) was identified as a positive regulator of SNC1 expression through its isolation as an snc1 and bon1 suppressor (Li et al. 2010 , Bao et al. 2014 . MOS1 is involved in transcriptional control (Bao et al. 2014) and is implicated in epigenetic modification at the SNC1 locus (Li et al. 2010) .
Expression of NLR genes was recently shown to be modulated at the chromatin level. Chromatin remodeling, carried out by histone modification enzymes and ATP-dependent chromatinremodeling complexes, is critical for multiple biological processes especially gene expression regulation (Zhang 2008 ). Histone modifications have been shown to be important for plant immune responses (Dhawan et al. 2009 , Alvarez et al. 2010 , Berr et al. 2010 , Jaskiewicz et al. 2011 , De-La-Pena et al. 2012 , Luna et al. 2012 , Xia et al. 2013 , Lee et al. 2016 ) and some modifications are involved in regulating NLR genes including SNC1. For instance, the expression of SNC1 is increased upon infection by the virulent pathogen Pseudomonos syringae pv. tomato DC3000 (Pst DC3000) and this induction is associated with an increase of monoubiquitination of histone 2B (H2Bub1) at the SNC1 locus (Zou et al. 2014 ). An increase of H2Bub1 at the SNC1 gene is also seen in the autoimmune mutant bon1 Hua 2004, Zou et al. 2014 ). In contrast, the level of H2Bub1 at the SNC1 gene is significantly reduced in the LOF mutant of two histone methyltransferase SET DOMAIN GROUP8 (SDG8) and SDG25 compared with the wild type (Lee et al. 2016) . For another NLR gene, LAZ5 (LAZARUS 5), trimethylation of Lys36 of histone 3 (H3K36m3) in the locus was increased in the autoimmune mutant acd11 (accelerated cell death 11) compared with the wild type (Palma et al. 2010 ). In addition, histone modification enzymes are found to impact plant disease resistance in addition to their role in NLR gene expression. For instance, the Arabidopsis LOF mutant of the histone E3 ubiquitin ligase HUB1 (HISTONE MONOUBIQUITINATION 1) had increased susceptibility to Alternaria brassicicola (Dhawan et al. 2009 ), the sdg8 LOF mutant has reduced basal and NLR-mediated resistance to Pseudomonas syringae (Palma et al. 2010 , Lee et al. 2016 and the sdg25 LOF mutant is more susceptible to Hyaloperonospora arabidopsidis, Botrytis cinerea and P. syringae than the wild-type Arabidopsis (Xia et al. 2013 , Lee et al. 2016 .
ATP-dependent chromatin-remodeling factors also play critical roles in plant immunity (Ding and Wang 2015) , and two of them are implicated in NLR gene regulation. SPLAYED (SYD) in the SNF2 subfamily is a negative regulator of the transcript level of SNC1 (Johnson et al. 2015) . SYD, together with its closest homolog BRAHMA (BRM), also regulate expression of several SA-respondive genes including PR1, PR2 and PR5 (Bezhani et al. 2007 ). DDM1 (DECREASED DNA METHYLATION1) in the LSH subfamily was shown to function antagonistically with MOS1 to modulate the expression of SNC1, and the reduction of SNC1 expression in snc1 mos1 compared with snc1 was reverted by the ddm1 LOF mutation (Li et al. 2010) .
CHR5 (Chromatin-Remodeling Factor 5) is a member of the Chd subfamily of chromatin-remodeling factor genes in Arabidopsis consisting of CHR5, CHR4, CHR7 and PICKLE (PKL) (Hu et al. 2014) . The Arabidopsis CHR5 is highly homologous to the Chd1 genes in yeast and animals, and is the only member of the Chd1 group in Arabidopsis (Shen et al. 2015) . Chd1 proteins from yeast, Drosophila and human are localized to actively transcribed genes and are implicated in nucleosome assembly and positioning as well as histone modification and RNA splicing (Simic et al. 2003 , Lusser et al. 2005 , Stockdale et al. 2006 , Konev et al. 2007 , Gaspar-Maia et al. 2009 , Gkikopoulos et al. 2011 , Skene et al. 2014 , Siggens et al. 2015 , Lee et al. 2017 . Chd1 proteins play a key role in stress responses in yeasts and animals. LOF mutations of the CHD1 genes ISW1 (Imitation Switch 1) and ISW2 in yeast are synthetic lethal under several stress conditions (Tsukiyama et al. 1999) . Human Chd1 genes hCHD1 and hCHD2 are both implicated in cancer and virus resistance (Nagarajan et al. 2009 , Burkhardt et al. 2013 ) . In addition, hCHD1 positively regulates infection and multiplication of viruses, probably through enhancing viral RNA transcription (Rodgers et al. 2014 , Marcos-Villar et al. 2016 . In Drosophila, CHD1 is a positive regulator of immunity, and the loss of CHD1 function renders flies susceptible to infection by the Gram-negative bacterium Pseudomonas aeruginosa (Sebald et al. 2012) . These studies indicate that Chd1 genes have critical functions in immunity in yeasts and animals. The roles of Chd1 genes in plants are still largely unknown. In Arabidopsis, the Chd1 gene CHR5 was first revealed as a hypocotyl growth regulator in the absence of PKL, another member of the Chd subfamily (Jing et al. 2013) . Recently, CHR5 was showed to promote expression of some seed maturation genes which is associated with altered nucleosome occupancy and an increased level of H3K27 trimethylation (Shen et al. 2015) . The CHR5 LOF mutant is also more sensitive to UV-C treatment than the wild type (Shaked et al. 2006) , indicating a broader role for CHR5 in Arabidopsis.
Here, we report the identification of the Chd1 chromatin remodeler gene CHR5 as a positive regulator of SNC1 expression as well as SNC1-independent plant immunity. In addition, we found an involvement of CHR5 in nucleosome occupancy at the whole-genome level. We postulate that the plant Chd1 gene CHR5 regulates immune responses and NLR gene expression via chromatin remodeling including nucleosome occupancy.
Results
Loss of CHR5 function suppresses growth defects in the bon1 mutant In a search for additional regulators of SNC1, we analyzed MOS1 co-expression genes for their potential roles in autoimmune responses in bon1 (Zou et al. 2014 ). An LOF mutation in CHR5, a MOS1 co-expression gene, was found largely to suppress the growth defects of bon1. The chr5-1 (SALK_020296) mutant line from the T-DNA insertion line collection (Alonso et al. 2003 ) contains a T-DNA insertion in the 21st intron and had no detectable expression of CHR5 ( Supplementary Fig. S1 ). The chr5-1 bon1 double mutant had a larger rosette and less twisted leaves than the bon1 mutant (Fig. 1A) . To verify that this suppression was caused by the CHR5 mutation, we analyzed another CHR5 LOF mutant allele chr5-2 (SAIL_504_D01) where T-DNA was inserted in the third exon ( Supplementary Fig. S1 ). The double mutant chr5-2 bon1 was generated and it exhibited a largely wild-type phenotype (Fig. 1A) . We further transformed the chr5-1 bon1 double Fig. 1 The loss-of-function mutation of CHR5 largely suppresses growth and immunity defects in bon1. (A) Growth phenotypes of wild-type Col-0, bon1-1 (bon1), chr5-1, chr5-2, chr5-1 bon1-1 (chr5 b1) and chr5-2 bon1-1 (chr5-2 b1) plants at 3 weeks old. (B) Growth phenotypes of wild-type Col-0, bon1, chr5-1, chr5 bon1 and two representative p35S:CHR5/chr5 bon1 (p35S:CHR5/chr5 b1) plants at 3 weeks old. (C) Growth of Pst DC3000 in wild-type Col-0, bon1, chr5 and chr5 b1 plants at 0 and 3 d post-inoculation as the log10 value of cfu (colony-forming units) mg -1 FW. Shown are means ± SDs (n=3). Similar results were obtained in three independent experiments. (D) Quantification of SA levels in wild-type Col-0, bon1, chr5-1 and chr5 b1 plants grown in soil for 3 weeks at 22 C. Shown are means ± SDs (n=3) from three biological repeats. (E) Staining of wild-type Col-0, bon1, chr5-1, chr5-2, chr5-1 b1 and chr5-2 b1 plants by 3, 3 0 -diaminobenzidine (DAB) to show the accumulation of H 2 O 2 . (F and G) Expression of SNC1 (F) and PR1 (G) in Col-0, bon1, chr5-1 and chr5 b1 assayed by RNA blots. rRNAs were used as loading controls. In (C) and (D), different letters indicate statistically significantly different levels (Student-Newman-Keuls test, a = 0.05). mutant with a CHR5 cDNA under the control of the 35S promoter of Cauliflower mosaic virus. Among the 16 transgenic lines obtained, 13 exhibited a bon1-like morphology (Fig. 1B) . Taken together, we conclude that the loss of CHR5 function suppresses the growth defects of bon1.
CHR5 function is required for the autoimmune responses and up-regulation of SNC1 in the bon1 mutant
Because the bon1 growth defect results from autoimmunity (Yang and Hua 2004 ), we determined whether or not the enhanced disease resistance phenotype was suppressed by the CHR5 mutation. Growth of the virulent pathogen Pst DC3000 was assayed in the wild-type Col-0, bon1 and chr5 bon1 plants. As previously reported, the bon1 mutant exhibited an enhanced disease resistance compared with the wild type (Fig. 1C) . The enhanced resistance in bon1 was significantly reduced, although not abolished, in the chr5 bon1 double mutant (Fig. 1C) . Consistent with the disease resistance phenotype, the accumulation of SA and reactive oxygen species was dramatically decreased in chr5 bon1 compared with bon1 ( Fig. 1D, E) .
Because up-regulation of SNC1 is responsible for the autoimmunity in bon1 (Yang and Hua 2004 ), we determined whether or not CHR5 affects the expression of SNC1. Quantitative reverse transcription-PCR (qRT-PCR) revealed that SNC1 expression was drastically reduced in chr5 bon1 compared with bon1 ( Fig. 1F) . Similarly, expression of the defense response marker gene PR1 was also reduced (Fig. 1G) . Therefore, CHR5 is required for autoimmune responses in bon1 which is dependent on the up-regulation of SNC1 expression.
A previous study found that differential RNA splicing could affect the SNC1 expression level (Xu et al. 2012 ) and the homologous gene of CHR5 in human was recently found to affect mRNA splicing (Lee et al. 2017) . We therefore tested whether or not the splicing pattern is altered in the chr5 mutant and therefore resulted in an altered SNC1 expression level. Different mRNA forms of SNC1 were detected by semi-quantitative RT-PCR using primers spanning introns of the SNC1 gene. No significant differences were detected in any of the splicing forms we analyzed in Col-0, chr5, bon1 and chr5 bon1 grown at both 22 and 28 C ( Supplementary Fig. S2 ). Therefore, CHR5 may have no direct effect on the splicing of the SNC1 gene.
CHR5 is required for autoimmune responses in snc1
To investigate if CHR5 is required for the autoimmune phenotypes of snc1 where SNC1 is up-regulated similarly to the case in bon1, we generated a double mutant between chr5-1 and snc1. The dwarf stature and the curly leaf phenotype of snc1 were completely suppressed by the CHR5 mutation ( Fig. 2A) . Consistent with the growth phenotype, resistance to the virulent pathogen Pst DC3000 and constitutive accumulation of reactive oxygen species were greatly reduced in chr5 snc1 compared with snc1 ( Fig. 2B, C) . Thus, CHR5 is required for autoimmune responses in snc1, suggesting that CHR5 is involved in the feedback transcriptional regulation of SNC1.
CHR5 regulates expression of SNC1, RPP4 and At4g16950 in the RPP5 gene cluster Because SNC1 can be co-regulated with other NLR genes in the RPP5 gene cluster (Yi and Richards 2007 , Xia et al. 2013 , Zou et al. 2014 , we tested if CHR5 affects expression of two other genes, RPP4 and At4gl6950, in the cluster. Similar to SNC1 (Fig.  3A) , these two genes are up-regulated in the bon1 mutant (Fig.  3B, C) . qRT-PCR analysis revealed that the up-regulation of RPP4 and At4gl6950 in bon1 was inhibited by the chr5 mutation (Fig. 3B, C) . No obvious difference in SNC1 gene expression was observed in the chr5 single mutant compared with the wild type ( Fig. 1F ; Supplementary Fig. S3 ). Therefore, CHR5 modulates expression of multiple genes in the RPP5 gene cluster.
CHR5 regulates the expression of SNC1 in a locus-specific manner
The co-regulation of genes in the RPP5 gene cluster suggests that CHR5 exerts its function over the gene cluster rather than limited to the confined SNC1 local sequences. We therefore tested whether or not CHR5 regulates SNC1 gene expression in a locus-specific manner. A transgenic line carrying an SNC1 genomic fragment inserted at an exogenous location was tested for the requirement for CHR5 for its expression. This pSNC1::SNC1 transgenic line had a bon1-or snc1-like autoimmune dwarf phenotype, probably due to a higher expression of this transgene than of the endogenous SNC1 (Li et al. 2007 ). This pSNC1::SNC1 transgenic line was crossed to the chr5 mutant, and chr5 plants with the pSNC1::SNC1 transgene were identified in the F 2 population. The pSNC1::SNC1 chr5 plants had a dwarf phenotype, similar to the pSNC1::SNC1 transgene plants in the wild-type background (Fig. 4A) . We then analyzed the expression of SNC1 in pSNC1::SNC1 transgenic lines in the wild-type and chr5 background by qRT-PCR. A similar level of SNC1 expression was observed in pSNC1::SNC1 transgenic plants with or without the chr5 mutation (Fig. 4B) . Therefore, CHR5 does not impact the expression of SNC1 as a transgene as it does on SNC1 at the endogenous location in SNC1-induced autoimmune mutants.
The loss of DDM1 function enhances SNC1 expression in the bon1 and snc1 mutants The DDM1 gene is reported to be required for the mos1 mutation to suppress SNC1 expression, because the snc1 mos1 ddm1 plant, unlike snc1 mos1, behaved like snc1 (Li et al. 2010) . We therefore tested whether or not DDM1 affects SNC1 expression. First, we generated the double mutants of ddm1 bon1 and ddm1 snc1. Interestingly, both double mutants had more severe growth defects than the bon1 or snc1 single mutants when grown at 22 C (Fig. 5A, B) . In addition, the SNC1 expression was increased in the ddm1 bon1 and ddm1 snc1 mutants compared with the bon1 or snc1 single mutants, although it was not altered in the ddm1 single mutant compared with the wild type (Fig. 5C, D) . However, despite the increase of SNC1 expression, ddm1 snc1 supported the same amount of growth of Pst DC3000 as snc1 (Fig. 5E) . Together, these analyses indicate that the ddm1 mutation enhances the expression of SNC1 in a bon1 and snc1 background, but it does not significantly impact the autoimmunity of snc1 or bon1.
Analysis of genetic interaction between DDM1 and CHR5 on SNC1-mediated autoimmunity
We subsequently analyzed the genetic interaction of CHR5 and DDM1 in the bon1 and snc1 background. Triple mutants of chr5 ddm1 bon1 and chr5 ddm1 snc1 were generated by crossing. The chr5 mutation largely suppressed the dwarf phenotype of ddm1 bon1, and the chr5 ddm1 bon1 triple mutant resembled the chr5 bon1 mutant (Fig. 6A) . Similarly, but to a lesser extent, the chr5 mutation reduced the growth defect in ddm1 snc1, and the chr5 ddm1 snc1 mutant exhibited an intermediate phenotype between ddm1 snc1 and chr5 snc1 (Fig. 6B) . We further analyzed the expression of SNC1 in chr5 ddm1 snc1 by qRT-PCR and found that the chr5 ddm1 snc1 triple mutant had an SNC1 expression level in between those of chr5 snc1 and ddm1 snc1 (Fig. 6C) . Therefore, CHR5 appears to function antagonistically with DDM1, if not downstream of DDM1, in regulation of SNC1 expression.
DDM1 is required for silencing transposons via DNA methylation (Vongs et al. 1993 , Jeddeloh et al. 1999 ). To assess whether or not CHR5 plays a role in this process, we analyzed the DNA methylation status of several transposons in wild-type Col-0, bon1-1, ddm1-10 and chr5 ddm1 plants. We used a methylation-sensitive enzyme McrBC to digest genomic DNA followed by PCR assay to determine whether or not the region of interest is methylated (Gkikopoulos et al. 2011) . High levels of DNA methylation result in increased McrBC digestion and, consequently, reduced amplification by PCR. The PCR products of three transposons AtCOPIA4, AtMuI and AtGPI, in McrBCdigested samples were greatly decreased compared with those from undigested samples for the wild-type Col-0 and the bon1 mutant, but were only slightly reduced for ddm1 (Fig. 6D) . The chr5 ddm1 double mutant had a similar pattern to the ddm1 mutant (Fig. 6D) , indicating that CHR5 has little effect on DDM1-regulated DNA methylation of transposons.
CHR5 and HUB1 regulate SNC1 through different genetic pathways HUB1, like CHR5, is a MOS1 co-expression gene that is also involved in SNC1 regulation (Zou et al. 2014) . To determine whether and how CHR5 and HUB1 might interact to regulate SNC1 expression, we generated the triple mutant of chr5 hub1 bon1 by genetic crossing. This triple mutant had a more wildtype-like growth phenotype than either of the chr5 bon1 and hub1 bon1 double mutants (Fig. 7A) , suggesting an additive effect of chr5 and hub1 on bon1 growth defects. The two mutations were found to have an additive effect on the autoimmunity of bon1 as well. Each of the hub1 and chr5 mutations increased the growth of the virulent bacterial pathogen strain Pst DC3000 in bon1, and the double mutations further increased its growth in bon1 to the level in the wild type (Fig. 7B) . This suggests that CHR5 and HUB1 act independently to regulate SNC1 expression and that CHR5 might not be required for HUB1 to function. To test the latter hypothesis, we determined the level of H2Bub1 at the SNC1 gene locus in the bon1 chr5 mutant by chromatin immunoprecipitation (ChIP) with antibodies of H2Bub1. Similarly to what has been previously reported (Zou et al. 2014 ), H2BUb1 modification was increased at the SNC1 locus in the bon1 mutant compared with the wild type (Fig. 7C) . A similar increase of H2Bub1 was found at the SNC1 locus in chr5 bon1 compared with the wild type (Fig. 7C) , indicating that H2Bub1 at SNC1 is independent of CHR5. Therefore, CHR5 and HUB1 probably affect SNC1 expression separately through different genetic pathways.
CHR5 is a positive regulator of basal resistance to the bacterial pathogen To determine whether or not CHR5 is also involved in immune responses to pathogens independent of autoimmunity, we compared the growth of several P. syringae strains in the wild type and the chr5 mutant. They include virulent strains Pst DC3000 and Psm (Pseudomonas syringae pv maculicola) ES4326, avirulent strains Pst DC3000 (avrRpt2) and Pst DC3000 (avrRps4), as well as non-virulent strain Pst DC3000 (hrcU -). All these strains except Pst DC3000 had significantly more growth in chr5 mutant plants than in the wild type (Fig. 8) . The most virulent strain, Pst DC3000, grew slightly more in the chr5 mutant than in the wild type in each of the four biological repeats, but the difference was not found to be statistically significant (Supplementary Fig. S4 ). These results indicate that CHR5 is in general a positive regulator of both basal and NLR-mediated resistance to the bacterial pathogens. 
Nucleosome occupancy is altered in the chr5 mutant
The Chd1 genes in yeasts and animals regulate gene expression through mechanisms including nucleosome positioning. The multiple roles of CHR5 in plant development and immunity suggest that it may have a global role in gene expression regulation. We therefore analyzed nucleosome patterns in the chr5 mutant and the wild type to assess if altering nucleosome positions could be a mechanism for CHR5 to regulate various processes in plants. This was achieved by MNase-Seq, a highthroughput sequencing of DNAs in mononucleosomes protected from digestion by micrococoal nuclease (MNase). Approximately 150 million aligned reads were obtained for each of the wild type and the chr5 mutant, which offered a very high depth for nucleosome occupancy analysis.
We first examined nucleosome patterns around the TSS (transcription start site) by plotting nucleosome start sites on forward and reverse strands separately (Fig. 9A, B) . The start site is defined by the first nucleotide of each sequence read from MNase-Seq, and reads on the forward strand and those on the reverse strand are analyzed separately. The sum of nucleosome starts of all genes at the same position relative to the TSS was plotted from -500 bp to 500 bp relative to the TSS. Both the wild type and the chr5 mutant exhibited an oscillation pattern at regions 3 0 to the TSS with a phase of approximately 150 bp. The peaks on forward and reverse strands were approximately 130 bp apart, which is the expected length of DNA protected by nucleosomes. These patterns are consistent with previous reports (Chodavarapu et al. 2010 ). The same analysis was also done for each of five individual chromosomes, and similar patterns were found for the wild type and the chr5 mutant. These results indicate that the loss of CHR5 does not significantly impact the positions of nucleosomes genome wide.
Interestingly, we noticed differential nucleosome occupancy (amount) between chr5 and the wild type (Fig. 9C, D) . The ratios of nucleosome start sites in the mutant vs. the wild type were averaged around 1.15 in the 0 bp to -500 bp region relative to the TSS. The ratios were variable in the 0 bp to 500 bp region, but was centered at a ratio of 1.05. When each chromosome was analyzed separately, the mutant/wild type ratios were also found to be 1.1 for all genes in the same chromosome. Therefore, there was a relative increase of nucleosome start sites in the chr5 mutant at the 0 to -500 bp region at the genome scale. To differentiate whether this is due a change of all genes or in a subset of genes, we analyzed the ratio of nucleosome start site numbers of the wild type vs. the chr5 mutant in the gene body (from the TSS to +500 bp) and the promoter region (from -500 bp to the TSS) of each gene and plotted the distribution of the ratios of all genes. Ratios of the majority of genes either in the gene body or the promoter fell at around 1, but a portion of genes had a higher ratio of the mutant vs. the wild type in the promoter region (Fig. 9E) , indicating that a subset of genes have higher nucleosome occupancy in the mutant than in the wild type, especially in the promoter region.
Discussion
The expression and activity of plant immune receptor NLR genes are tightly regulated in plants. Some of these NLR genes are induced during pathogen invasion, and are likely to contribute to resistance to pathogens. However, their unintended de-repression could lead to constitutive defense responses and compromised plant growth. The switch mechanisms between repression and activation of these NLR genes are still not fully understood in plants. Here, we identified a chromatin-remodeling gene CHR5 as a critical component for the up-regulation of SNC1 and other NLR genes as well as autoimmunity in bon1 and snc1. Several other genes with putative chromatin-remodeling activities have previously been identified as regulators of SNC1 expression. These include H2B monoubiquitinases HUB1/2, histone methyltransferases SDG8, SDG25 and ARABIDOPSIS TRITHORAX1 (ATX1) as well as chromatin remodelers DDM1 and SYD (Alvarez-Venegas et al. 2006 , Luna et al. 2012 , Xia et al. 2013 , Zou et al. 2014 , Johnson et al. 2015 . The involvement of a large number of genes affecting chromatin structures in both positive and negative regulation of SNC1 expression indicates a highly orchestrated control of the chromatin architecture of the SNC1 locus perhaps for the fine control of immunity and growth.
Our study shed some lights on how these regulators work together to affect SNC1 expression. MOS1, a potential transcription regulator, was previously shown to suppress the bon1 and snc1 phenotypes induced by the endogenous SNC1 gene but not the immune responses induced by the SNC1 transgene (Li et al. 2010 , Bao et al. 2014 . Here, we found that chr5, similar to mos1, suppresses mutant phenotypes of snc1 and bon1 but not those of the SNC1 transgenic plants (Figs. 1, 2, 4) . In contrast, hub1 suppresses immune responses of bon1, snc1 and SNC1 transgenic plants (Zou et al. 2014) . Therefore, CHR5 and MOS1 may regulate the expression of SNC1 in a more similar Fig. 7 CHR5 and HUB1 regulate BON1-related immunity independently. (A) Growth phenotypes of wild-type Col-0, bon1-1, chr5-1, chr5 bon1, hub1-4, hub1 bon1 and chr5 bon1 hub1 plants at 3 weeks old. (B) Growth of Pst DC3000 in Col-0, bon1-1, chr5 bon1 (chr5 b1), hub1 bon1 (hub1 b1) and chr5 bon1 hub1 (chr5 b1 hub1) plants at 0 and 3 d post-inoculation as log10 value of cfu mg -1 FW. Values represent the mean ± SD (n = 3). Similar results were obtained in three independent experiments. (C) ChIP analysis of the level of H2Bub1 in the P2 region of SNC1 (as described in Zou et al. 2014) in Col-0, bon1-1 and chr5 bon1. Shown is the relative amount from the ChIP sample vs. total input. Shown are the data of three technical repeats of one biological experiment. Similar results were obtained from two biological repeats. No Anti, no antibody. Anti, antibody. In (B) and (C) different letters indicate statistically significantly different levels (Student-Newman-Keuls test, a = 0.05). manner than HUB1. In addition, there was no significant difference in the level of H2Bub1 at the SNC1 locus between bon1 and chr5 bon1 (Fig. 7C) , and hub1 and chr5 mutations have an additive effect in suppressing the autoimmunity phenotype in bon1 (Fig. 7A, B) . These data indicate that CHR5 activity and HUB1 probably affect SNC1 expression independently. SNC1 expression is also regulated positively by the H3K4me3 and H3K36me3 trimethylation level through SDG25 and SDG8 (Luna et al. 2012 , Xia et al. 2013 . In yeast and human, Chd1 function is required for H3K4me3 and H3K36 trimethylation (Sims et al. 2005 , Lee et al. 2017 ). It will be interesting to determine whether or not H3K4me3 and H3K36me3, carried out by SDG25 and SDG8, are dependent on CHR5, the Chd1 gene in Arabidopsis.
DDM1 is another chromatin-remodeling factor gene previously implicated in SNC1 regulation in the snc1 mos1 background (Li et al. 2010 ). Here we observed an enhancement of the bon1 and snc1 defect and an associated enhancement of SNC1 up-regulation by ddm1, although the ddm1 mutation alone does not significantly affect the expression of SNC1 (Fig. 5) . Perhaps the function of DDM1 and CHR5 in SNC1 regulation is only prominent when SNC1 expression reaches a threshold level as in the bon1 or snc1 mutants. The effects of the chr5 mutation and the ddm1 mutation on SNC1 expression and growth were opposite and additive in snc1 and bon1, although chr5 was slightly epistatic to ddm1 in bon1 (Fig. 6) . These data suggest that the two remodelers DDM1 and CHR5 function through distinct mechanisms in terms of regulation of SNC1 expression.
This study also identifies a role for CHR5 in plant immunity in addition to its role in autoimmunity. The chr5 mutant is more susceptible to virulent and avirulent, and non-virulent bacterial pathogens (Fig. 8) , indicating a positive regulation of basal resistance by CHR5. The animal homologs of CHR5, Chd1 genes, are also implicated in immunity and disease resistance. Therefore, the importance of Chd1 proteins in immunity against pathogens is conserved from plants to animals. It will be interesting to identify target genes of CHR5 for its regulation of immunity in wild-type Arabidopsis. SNC1 is unlikely to be the main regulatory target of CHR5 in resistance to the bacterial strains tested here because SNC1 LOF mutation does not significantly impact the resistance (Yang and Hua 2004) . However, NLR genes similar to SNC1 could be directly regulated by CHR5 and contribute to disease resistance. It is likely that multiple genes regulated by CHR5 contribute to immune responses. Future studies on CHR5 will contribute to the understanding of disease resistance and the chromatin-remodeling mechanisms.
This study provides new information on the role of CHR5 in chromatin structure at the genome level. Chd1 proteins in yeasts and humans are shown to have nucleosome assembly and nucleosome spacing function (Gkikopoulos et al. 2011 , Skene et al. 2014 . In Arabidopsis, the LOF mutant of CHR5 does not significantly affect nucleosome positions around the TTS (Fig. 9A, B) , but it increases the nucleosome occupancy in the promoter region of -500 bp to 0 bp of genes genome wide (Fig. 9C, D) . In yeast, the chd1 mutation is reported to reduce the nucleosome spacing at the gene body region especially together with the isw1 mutation ( fig.1 in Gkikopoulos et al. 2011) . Closer examination of the nucleosome occupancy in fig. 1C of Gkikopoulos et al. (2011) reveals a higher nucleosome occupancy in the chd1 mutant in the promoter region, especially the first nucleosome 5 0 to the TSS, but a lower occupancy in the gene body region in yeasts. This indicates that the Chd1 proteins might have a conserved function in reducing nucleosome occupancy in the immediate promoter region to facilitate gene transcription. This effect is exerted on a subset of genes, but not all genes (Fig. 9E) . Consistently, a previous study found an increase of nucleosomes in the promoter region of FUS3 but not LEC2, both of which have reduced expression in the chr5 mutant (Shen et al. 2015) . We did not see a significant change in nucleosome occupancy at the SNC1 locus in chr5 compared with the wild type, and future studies will determine whether or not nucleosome occupancy at this locus is altered in bon1 in a CHR5-dependent manner. It will be interesting to investigate further which group of genes is especially affected by the loss of CHR5 function in terms of nucleosome occupancy and gene expression. Reducing nucleosomes in the immediate promoter region by CHR5 will facilitate the expression of those genes perhaps more responsive to developmental and environmental signals. Reduction of expression of genes which are needed might result in higher susceptibility to pathogesn and reduced plant growth in the chr5 mutant compared with the wild type. Future study of CHR5 in plant immunity should further our understanding of the mode of action of Chd1 proteins in chromatin remodeling and its regulatory mechanisms in gene expression.
Materials and Methods

Materials and plant growth conditions
Sequence data from this article can be found in TAIR (https://www.arabidopsis. org) under the following accession numbers: CHR5 (AT2G13370), HUB1 (AT2G44950), DDM1 (AT5G66750), SNC1 (AT4G16890), PR1 (AT2G14610), RPP4 (AT4G16860), AT4G16950. Arabidopsis plants were grown on soil at 22 or 28 C with relative humidity between 40% and 60%. Plants for pathogen tests were grown under a 12 h light/12 h dark photoperiod, and plants for morphological phenotyping were grown under constant light.
RNA expression analysis
Total RNA was extracted from 2-week-old plants using the Trizol reagent according to the manufacturer's instructions (Invitrogen). A 20 mg aliquot of total RNA per sample was used for RNA gel-blot analysis according to the standard procedure. RNA blots were hybridized with gene-specific, 32 P-labeled, singlestranded DNA probes. For reverse transcription, 1 mg of total RNA was used as template for first-strand cDNA synthesis with oligo(dT) primer by the SuperScript III Kit (Invitrogen). qRT-PCR was performed by using a SYBR Green Supermix with gene-specific primers in a Bio-Rad CFX96 real-time PCR detection system (Bio-Rad). Arabidopsis ACTIN2 was used as a control gene for normalization. Expression levels were calculated by the comparative cycle threshold method.
Plant transformation and transgenic plants selection
The CHR5 full-length cDNAs were cloned into the pDONR221 entry vector and subcloned into the PMDC32 destination vector to generate the overexpression constructs that were transformed into chr5-1 bon1. Transgenic plants were selected with 50 mg ml -1 hygromycin on Murashiuge and Skoog (MS) plates.
Disease resistance-related assays
The bacterial growth in Arabidopsis was performed using the dipping inoculation method as previously described (Zou et al. 2014 ). Quantification of SA was performed as previously described (Pan et al. 2008 ). 3,3-Diaminobenzidine (DAB) staining was performed as previously described (Zou et al. 2014) .
McrBC-PCR analysis
McrBC-PCR analysis was performed as described previously (Gkikopoulos et al. 2011) . A total of 200 ng of genomic DNAs from 2-weeks-old plants was digested with 10 U of McrBC endonuclease (New England Biolabs) overnight at 37 C. A 10 ng aliquot of DNA from digestion or mock digestion was used as a template for PCR in a 20 ml reaction with 28 cycles of amplification for each primer pair (Supplementary Table S1 ).
ChIP analysis
The ChIP experiment was performed as described previously (Zou et al. 2014 ).
Nuclear extraction and MNase treatment
The nuclear extraction and MNase treatment were performed according to previously described methods (Zhang et al. 2015) , with slight modifications. Briefly, 8 g of 2-week-old Arabidopsis seedlings grown on 1/2 MS medium were collected and ground into a fine powder in liquid nitrogen. Pre-chilled nuclei isolation buffer (10 mM Tris-HCl, 80 mM KCl, 10 mM EDTA, 1 mM spermidine, 1 mM spermine, 0.15% mercaptoethanol, 0.5 M sucrose, pH 9.5) was added to the powder at an approximately 1 : 1 volume ratio. The well-mixed slurry solution was then filtered through a folded four-layer Miracloth (Calbiochem) into a new 50 ml centrifuge tube. The filtrate was centrifuged at 3,500 r.p.m. for 10 min at 4 C. The nuclear pellet was washed three times by resuspending it in nuclei washing buffer (nuclei isolation buffer plus 0.5% Triton X-100) followed by centrifugation at 3,500 r.p.m. for 10 min at 4 C. A 10 ml volume of MNase buffer (10% sucrose, 50 mM Tris-HCl, 4 mM MgCl 2 and 0.1 mM CaCl 2 ) was added to equilibrate the purified nuclei, and the sample was centrifuged at 3,500 r.p.m. for 10 min at 4 C. After removing the supernatant, the obtained nuclei were resuspended in 5 ml of MNase buffer for subsequent MNase digestion.
For MNase treatment, the prepared nuclei were divided into five portions. Each portion was digested with a series of concentrations of MNase (catalog# N5386, Sigma) for 10 min at 37 C. The digestion was stopped by addition of 15 ml of 0.5 M EDTA. MNase-digested DNA was purified by phenol:chloroform extraction and ethanol precipitation. The five purified DNA samples were separated on a 2% agarose gel, and DNA with approximately 80% monomer and 20% dimer was chosen for recovery of mononucleosomal DNA. The DNA band corresponding to approximately 150 bp was cut out of the gel and recovered with a Gel Purification kit (Qiagen, http://www.qiagen.com/).
MNase-Seq analysis
Approximately 1 mg of purified MNase-digested mononucleosomal DNA was used for Illumina library generation following the manufacturer's instructions (Illumina, http://www.illumina.com/). Library construction and deep sequencing were performed using Illumina HiSeq 2000 following the manufacturer's instructions (Illumina). The BWA alignment tool (Li and Durbin 2009 ) was used to map the sequencing reads to the Arabidopsis reference genome v10 with default setting. The TSS of each annotated genes was obtained from the TAIR database (www.arabidopsis.org). The number of reads with sequencing start sites at each position was counted from 500 bp upstream to 500 bp downstream of the TSS. Reads on the same strand and on the opposite strand of the gene were calculated independently. The counts of the read start sites with the same distance to the TSS for all genes were then combined and plotted. Ratios of start site reads at each position between the wild type and mutant were calculated after the total reads of the two genotypes were normalized.
Supplementary data
Supplementary data are available at PCP online. 
